July 15, 2025

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Look at Its 34% Potential Upside

Guardian Pharmacy Services, Inc. (GRDN), a significant player in the healthcare sector, specializes in providing technology-enabled pharmacy services to long-term care facilities (LTCFs) across the United..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

Clover Health Investments (CLOV) Stock Analysis: Exploring a 56% Potential Upside

Clover Health Investments, Corp (CLOV), a key player in the healthcare plans industry, is garnering attention from investors with its attractive potential upside of 56.25%. As..

SS Innovations International (SSII) Stock Report: A Closer Look at This Healthcare Innovator’s Financial Landscape

SS Innovations International Inc. (SSII), a trailblazer in the healthcare sector, is carving out a niche in the medical devices industry. As a commercial-stage surgical robotics..

Ascentage Pharma Group International (AAPG): A High-Growth Biotech Stock with Challenging Prospects

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology firm based in Suzhou, China, is making waves in the healthcare sector with its focus on developing innovative..

Organon & Co. (OGN) Stock Analysis: Exploring a 42.71% Upside Potential Amid Healthcare Market Challenges

For investors seeking opportunities in the healthcare sector, Organon & Co. (NYSE: OGN) presents a compelling case with its diversified portfolio in women’s health, biosimilars, and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 44.90% Potential Upside in Gene Editing

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the field of gene editing, represents a compelling opportunity within the biotechnology sector. With its innovative CRISPR/Cas9..

Acadia Healthcare (ACHC) Stock Analysis: Uncovering a Potential 78% Upside with Strong Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is capturing the attention of investors, as the company stands at a crucial juncture with significant upside potential. With a..

Scholar Rock Holding Corporation (SRRK): Analyst Consensus Points to 28.7% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a biopharmaceutical company operating within the dynamic biotechnology industry, is capturing investor attention with its promising pipeline and significant potential..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 108% Upside Potential in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) stands as a compelling figure in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $2.13 billion,..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem with 58.58% Potential Upside for Investors

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology industry, is drawing attention from investors with its robust revenue growth and impressive analyst ratings...

Progyny, Inc. (PGNY) Stock Analysis: Exploring the 11.84% Upside Potential in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) has emerged as a compelling player within the healthcare sector, specifically focusing on the niche of fertility and family building benefits management...

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A 78% Upside Potential in Biotech

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is capturing the attention of savvy investors with a compelling narrative in the biotechnology sector. As a leading player in the..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Healthcare Play with 67.9% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) stands as a noteworthy player in the healthcare sector, specializing in medical devices that cater to the surgical treatment of spinal..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A Biotech Powerhouse with a 27% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) is capturing investor attention with its promising growth prospects and robust pipeline in the biotechnology sector. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring the 119% Potential Upside Amid Strong Buy Ratings

For investors eyeing opportunities in the biotechnology sector, Denali Therapeutics Inc. (DNLI) presents a compelling case with its innovative approach to treating neurodegenerative diseases. Headquartered in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 39.55% Potential Upside Beckons Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors due to its substantial potential upside. With a market capitalization..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a 132.95% Potential Upside in Biotech

CG Oncology, Inc. (CGON), a prominent player in the biotechnology sector, is capturing investor attention with its compelling potential upside of 132.95%. This late-stage clinical biopharmaceutical..

Sotera Health Company (SHC) Stock Analysis: Navigating a 24.89% Potential Upside in Healthcare

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $3.3 billion, this..

Select Medical Holdings Corp (SEM) Stock Analysis: A 37% Upside Potential with Strong Buy Ratings

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the healthcare sector, is capturing investor attention not only with its robust market position but also..

Search

Funds

July 15, 2025

Search

Funds

July 15, 2025

FTSE 100

Funds